News Search

Category: School of Medicine

Penn Partners with PaxeraHealth to Build AI Algorithms for Ultrasound Research

The collaboration between Penn and PaxeraHealth will concentrate on developing imaging algorithms to detect liver cancer in addition to covid detection via lung ultrasounds.

Tribeca Film Festival Documentary Tells the Story of Penn Medicine and Children’s Hospital of Philadelphia’s Path to Cancer Therapy

Penn Medicine and Children’s Hospital of Philadelphia were in the spotlight at the Tribeca Film Festival in New York City, where the documentary “Of Medicine and Miracles" premiered.

COVID Vaccines and Boosters Provoke Robust Immune Response

Several new research studies reported in the New York Times have demonstrated that multiple doses of a COVID vaccine elicit a durable response in most people that protects them from serious illness

Newly discovered ‘encrypted peptides’ with antibiotic properties

A new study reports three distinct proteins in human plasma that have naturally occurring antibiotic properties. Global public health officials are concerned about the r

Decade-long remission after CAR T cell therapy

Two patients represent longest-known CAR T cell response to date, providing insight into treatment effect and outcomes.

The Center for Breakthrough Medicines and Penn partner in the manufacturing of gene therapies

Penn’s Innovation in Process Science combines with CBM manufacturing capability to develop large-scale gene therapy manufacturing capacity, testing, and analytics

Halting Progress and Happy Accidents: How mRNA vaccines were made

A New York Times feature on the history, research, challenges, and timeline to make the COVID-19 mRNA vaccines.

Moderna forms oncology collaboration with Carisma Therapeutics

Moderna will collaborate with Penn spinout Carisma Therapeutics to discover, develop and commercialize in-vivo engineered chimeric antigen receptor monocyte therapeutics for the treatment of cancer.

From foundational discoveries to profound impact

Without the mRNA technology foundation laid by Karikó and Weissman, the Pfizer/BioNTech and Moderna vaccines being deployed across the world would not exist.

Technology used in mRNA COVID vaccines offers hope for treatment of millions with heart disease, study suggests

Combining technologies that proved hugely success against cancer and in COVID-19 vaccines, researchers at Penn have shown they can effectively treat a leading cause of heart disease.


Skip to content